WHICH CONDITIONING REGIMEN IS MORE EFFECTIVE FOR HIGH-RISK PATIENTS WITH AML/MDS : COMPARING LOW-DOSE DECITABINE COMBINED WITH MODIFIED BUCY WITH MODIFIED BUCY FOLLOWED BY ALLO-HSCT

被引：0
|
作者：
Cao, J. [1 ]
Shi, X. [1 ]
Ge, L. [1 ]
Sun, A. [1 ]
Zhu, X. [1 ]
Qiu, H. [1 ]
Jin, Z. [1 ]
Miao, M. [1 ]
Fu, C. [1 ]
Ma, X. [1 ]
Chen, F. [1 ]
Xue, S. [1 ]
Han, Y. [1 ]
Xue, M. [1 ]
Mao, X. [1 ]
Wu, D. [1 ]
Tang, X. [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suzhou, Peoples R China
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P714
引用
收藏
页码：286 / 286
页数：1
相关论文
共 19 条
  • [1] Which conditioning regimen is more effective for high-risk patients with acute myeloid leukaemia/myelodysplastic syndrome: comparing Low-dose decitabine combined with modified BUCY with modified BUCY followed by allogeneic stem cell transplantation
    Cao, J.
    Shi, X.
    Ge, L.
    Sun, A.
    Zhu, X.
    Qiu, H.
    Jin, Z.
    Miao, M.
    Fu, C.
    Ma, X.
    Chen, F.
    Xue, S.
    Han, Y.
    Xue, M.
    Mao, X.
    Wu, D.
    Tang, X.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S443 - S443
  • [2] Low-Dose Decitabine Combined with Modified Bucy Is More Effective Conditioning Regimen for High-Risk Patients with Acute Myeloid Leukaemia/Myelodysplastic Syndrome
    Tang, Xiaowen
    Cao, Jing
    Shi, Xiaojing
    Ge, Ling
    Sun, Aining
    Zhu, Xiaming
    Qiu, Huiying
    Jin, Zhengming
    Miao, Miao
    Fu, Chengcheng
    Ma, Xiao
    Chen, Feng
    Xue, Shengli
    Han, Yue
    Xue, Mengxing
    Mao, Xinliang
    Wu, Depei
    BLOOD, 2016, 128 (22)
  • [3] LOW-DOSE DECITABINE COMBINED WITH MODIFIED BUCY AS CONDITIONING REGIMENT FOLLOW BY ALLOGENEIC STEM CELL TRANSPLANTATION FOR THE TREATMENT OF ADVANCED AML/MDS PATIENTS
    Shi, X.
    Ge, L.
    Sun, A.
    Zhu, X.
    Qiu, H.
    Jin, Z.
    Miao, M.
    Fu, C.
    Ma, X.
    Chen, F.
    Xue, S.
    Han, Y.
    Xue, M.
    Tang, X.
    Wu, D.
    HAEMATOLOGICA, 2015, 100 : 122 - 122
  • [4] Low-dose decitabine combined with modified BUCY as conditioning regiment follow by allogeneic stem cell transplantation for the treatment of advanced AML/MDS patient
    Tang, X.
    Shi, X.
    Wu, D.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S445 - S446
  • [5] Comparative analysis of Decitabine intensified BUCY2 and BUCY2 conditioning regimen for high-risk MDS patients undergoing allogeneic hematopoietic stem cell transplantation
    Ran Zhang
    Xuan Lu
    Liang V. Tang
    Hua-Fang Wang
    Han Yan
    Yong You
    Zhao-Dong Zhong
    Wei Shi
    Ling-Hui Xia
    Bone Marrow Transplantation, 2022, 57 : 1063 - 1071
  • [6] Comparative analysis of Decitabine intensified BUCY2 and BUCY2 conditioning regimen for high-risk MDS patients undergoing allogeneic hematopoietic stem cell transplantation
    Zhang, Ran
    Lu, Xuan
    Tang, Liang V.
    Wang, Hua-Fang
    Yan, Han
    You, Yong
    Zhong, Zhao-Dong
    Shi, Wei
    Xia, Ling-Hui
    BONE MARROW TRANSPLANTATION, 2022, 57 (07) : 1063 - 1071
  • [7] Low-dose decitabine-intensified modified conditioning regimen alleviates aGVHD in AML/MDS patients treated with allogeneic hematopoietic stem cell transplantation
    Zhu, Jinye
    Wang, Qingya
    Ren, Hanyun
    Dong, Yujun
    Yin, Yue
    Wang, Qian
    Liang, Zeyin
    Liu, Wei
    Wang, Qingyun
    Wang, Bingjie
    Li, Yuan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [8] OUTCOME OF HIGH-RISK AND REFRACTORY AML/MDS PATIENTS RECEIVING A FLAMSA SEQUENTIAL CHEMOTHERAPY REGIMEN FOLLOWED BY REDUCED-INTENSITY CONDITIONING (RIC) AND ALLOGENEIC HEMATOPOEITIC STEM CELL TRANSPLANTATION (allo-HSCT)
    Detrait, M.
    Chevallier, P.
    Sobh, M.
    Guillaume, T.
    Thomas, X.
    Morisset, S.
    Tedone, N.
    Delaunay, J.
    Nicolini, F.
    Ducastelle, S.
    Chelghoum, Y.
    Barraco, F.
    Labussiere, H.
    Mohty, M.
    Michallet, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S335 - S336
  • [9] Efficacy and safety of low-dose TBI combined MAC regimen for HSCT in high-risk AML patients with active disease
    Chen, Can
    Fan, Yang
    Xu, Ying
    Xie, Yaping
    Chen, Kuang
    Huang, Xilian
    Gao, Daquan
    Tan, Junfeng
    Liu, Lirong
    Qian, Shenxian
    Shi, Pengfei
    ANNALS OF MEDICINE, 2025, 57 (01)
  • [10] Outcome of High-Risk and Refractory AML/MDS Patients Receiving a FLAMSA Sequential Chemotherapy Regimen Followed by Reduced-Intensity Conditioning (RIC) and Allogeneic Hematopoeitic Stem Cell Transplantation (allo-HSCT)
    Detrait, Marie Y.
    Chevallier, Patrice
    Sobh, Mohamad
    Guillaume, Thierry
    Thomas, Xavier
    Morisset, Stephane
    Tedone, Nathalie
    Delaunay, Jacques
    Nicolini, Franck E.
    Labussiere, Helene
    Ducastelle, Sophie
    Fattoum, Jihane
    Barraco, Fiorenza
    Cannas, Giovanna
    Chelghoum, Youcef
    Mohty, Mohamad
    Michallet, Mauricette
    BLOOD, 2011, 118 (21) : 853 - 854
12